Sinonasal and ear manifestations of Erdheim-Chester disease

Br J Haematol. 2023 Oct;203(2):194-201. doi: 10.1111/bjh.18963. Epub 2023 Jul 2.

Abstract

To calculate the prevalence of sinonasal and ear involvement in an Erdheim-Chester disease (ECD) population, to describe the different ear, nose and throat (ENT) manifestations and to study the association between ENT involvement, other organ involvement, and BRAF mutations. We led a retrospective monocentric study in the national referral center for ECD. One hundred and sixty-two patients with ECD and ENT data were included between January 1, 1980 and December 31, 2020. Ear and nose clinical and radiological findings were noted. We described and studied the prevalence of ENT involvement in ECD population. The association between sinonasal and ear involvement, other organ involvement, and BRAF mutations was calculated. The prevalence of ENT manifestations is around 45%. No clinical rhinologic or otologic signs were specific to ECD. Sinus imaging was abnormal in 70% of cases. A bilateral maxillary sinus frame osteosclerosis was highly specific of ECD. Associations were found between the sinus MRI imaging type and BRAF status, central nervous system involvement, cerebellum involvement and xanthelasma. Sinonasal or ear involvement is frequent in ECD and has specific imaging features for sinuses. Trial registration: #2011-A00447-34.

Keywords: Erdheim-Chester; ear; histiocytes; imaging; inflammation; nose.

MeSH terms

  • Erdheim-Chester Disease* / complications
  • Erdheim-Chester Disease* / diagnostic imaging
  • Humans
  • Mutation
  • Proto-Oncogene Proteins B-raf / genetics
  • Retrospective Studies

Substances

  • Proto-Oncogene Proteins B-raf